📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AlgoTx

1.1 - Company Overview

AlgoTx Logo

AlgoTx

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of topical hydrogel therapies for complex pain, developing ATX01 to inhibit nociceptive sodium channels for targeted relief in chemotherapy-induced peripheral neuropathy and erythromelalgia, with plans to address additional peripheral neuropathic pain conditions such as painful diabetic peripheral neuropathy and phantom limb pain.

Products and services

  • ATX01 for Chemotherapy-Induced Peripheral Neuropathy (CIPN): A topical hydrogel delivering targeted pain relief in CIPN by inhibiting specific nociceptive sodium channels for localized peripheral neuropathic modulation
  • ATX01 for Other Pain Indications: A topical hydrogel planned for peripheral neuropathic pain, including Painful Diabetic Peripheral Neuropathy and Phantom Limb Pain, enabling analgesia
  • ATX01 for Erythromelalgia: A topical hydrogel aimed at alleviating disabling burning pain and elevated skin temperature in Erythromelalgia, concentrating therapy on localized cutaneous sites

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AlgoTx

Basking Biosciences Logo

Basking Biosciences

HQ: United States Website
  • Description: Provider of commercialization of technology developed at Duke and Ohio State Universities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Basking Biosciences company profile →
Algynomics Logo

Algynomics

HQ: United States Website
  • Description: Provider of a research-stage pain diagnostics platform leveraging patient cohorts to deliver prospective data that identifies individuals at increased risk for chronic pain, enabling targeted preventive efforts and enhancing patient stratification in clinical trials to identify treatment responders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Algynomics company profile →
Adapt Pharma Logo

Adapt Pharma

HQ: United States Website
  • Description: Provider of therapeutic treatments for patients with special medical conditions, including NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adapt Pharma company profile →
Grin Therapeutics Logo

Grin Therapeutics

HQ: United States Website
  • Description: Provider of targeted therapies for rare, severe neurodevelopmental disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grin Therapeutics company profile →
Biogen Logo

Biogen

HQ: United States Website
  • Description: Provider of innovative biotechnology therapies in development for neurological and neurodegenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biogen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AlgoTx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AlgoTx

2.2 - Growth funds investing in similar companies to AlgoTx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AlgoTx

4.2 - Public trading comparable groups for AlgoTx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AlgoTx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AlgoTx

What does AlgoTx do?

AlgoTx is a provider of topical hydrogel therapies for complex pain, developing ATX01 to inhibit nociceptive sodium channels for targeted relief in chemotherapy-induced peripheral neuropathy and erythromelalgia, with plans to address additional peripheral neuropathic pain conditions such as painful diabetic peripheral neuropathy and phantom limb pain.

Who are AlgoTx's competitors?

AlgoTx's competitors and similar companies include Basking Biosciences, Algynomics, Adapt Pharma, Grin Therapeutics, and Biogen.

Where is AlgoTx headquartered?

AlgoTx is headquartered in France.

How many employees does AlgoTx have?

AlgoTx has 1,000 employees 🔒.

When was AlgoTx founded?

AlgoTx was founded in 2010 🔒.

What sector and industry vertical is AlgoTx in?

AlgoTx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AlgoTx

Who are the top strategic acquirers in AlgoTx's sector and industry

Top strategic M&A buyers and acquirers in AlgoTx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AlgoTx?

Top strategic M&A buyers groups and sectors for AlgoTx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AlgoTx's sector and industry vertical

Which are the top PE firms investing in AlgoTx's sector and industry vertical?

Top PE firms investing in AlgoTx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AlgoTx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AlgoTx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AlgoTx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AlgoTx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AlgoTx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AlgoTx?

The key public trading comparables and valuation benchmarks for AlgoTx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AlgoTx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AlgoTx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AlgoTx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AlgoTx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AlgoTx's' sector and industry vertical?

Access recent funding rounds and capital raises in AlgoTx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AlgoTx